Publish date: 1 December 2021

George Stacey 3.png
George Stacey and his partner Jill Clatworthy

Researchers in Liverpool are hoping to find a test that can pinpoint newly diagnosed people with diabetes who could be at risk of having pancreatic cancer – so they can be treated earlier.

More people than ever before in the UK are developing and living with diabetes, with the vast majority of them having type 2 of the condition, which is not normally linked with pancreatic cancer.

However, a lesser known form of diabetes is type 3C and people who develop this are at a much higher risk of also having pancreatic cancer.

This was the case for 76-year-old George Stacey, a patient at The Clatterbridge Cancer Centre.

Read about his experience here: https://www.clatterbridgecc.nhs.uk/news/clinical-researchers-look-test-pinpoint-people-diabetes-higher-risk-cancer